Pacira Pharmaceuticals Announces Timing for 2017 Financial Results Webcast and Conference Call
February 22 2018 - 4:00PM
Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced that it
will report its fourth quarter and year ended December 31, 2017
financial results before the open of the U.S. markets on Wednesday
February 28, 2018. The announcement will be followed by a
conference call at 8:30 a.m. ET. Participating in the call from
Pacira will be Dave Stack, chairman and chief executive officer,
and other members of the company’s senior management team.
The call can be accessed by dialing 1-877-845-0779 (domestic) or
1-720-545-0035 (international) ten minutes prior to the start of
the call and providing the Conference ID 5198726. A replay of the
call will be available approximately two hours after the completion
of the call and can be accessed by dialing 1-855-859-2056
(domestic) or 1-404-537-3406 (international) and providing the
Conference ID 5198726. The replay of the call will be available for
one week from the date of the live call.
The live, listen-only webcast of the conference call can also be
accessed by visiting the “Investors & Media” section of the
company’s website at investor.pacira.com. A replay of the webcast
will be archived on the Pacira website for two weeks following the
call.
About Pacira
Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) is a specialty
pharmaceutical company focused on the clinical and commercial
development of new products that meet the needs of acute care
practitioners and their patients. The company’s flagship product,
EXPAREL® (bupivacaine liposome injectable suspension), indicated
for single-dose infiltration into the surgical site to produce
postsurgical analgesia, was commercially launched in the United
States in April 2012. EXPAREL and two other products have
successfully utilized DepoFoam®, a unique and proprietary product
delivery technology that encapsulates drugs without altering their
molecular structure, and releases them over a desired period of
time. Additional information about Pacira is available at
www.pacira.com.
Investor Contact:
Pacira Pharmaceuticals, Inc.
Susan Mesco, (973) 451-4030
susan.mesco@pacira.com
Pacira BioSciences (NASDAQ:PCRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Pacira BioSciences (NASDAQ:PCRX)
Historical Stock Chart
From Apr 2023 to Apr 2024
